Arizona Tribune - CBD Life Sciences Inc. (CBDL) Secures Major Hemp Flower Order From Bronx Dispensary Smoking Scholars Amid Explosive Growth

SCOTTSDALE, ARIZONA / ACCESS Newswire / November 12, 2025 / CBD Life Sciences Inc. (OTC Pink:CBDL) proudly announces another significant order from Smoking Scholars, the rapidly growing dispensary located in the Bronx, New York - further solidifying CBDL's position as one of the most active and fast-expanding players in the cannabis and CBD marketplace.

Following the success of its previous headline-making partnership earlier this quarter, Smoking Scholars has placed a new bulk order featuring an elite trio of premium strains developed and supplied by The CBD Vault, a leading brand under the CBDL corporate structure:

• Hybrid: Hawaii Haze

• Sativa: Jet Fuel

• Indica: Purple Gas

Each strain represents The CBD Vault's commitment to quality cultivation and market-leading genetics - designed for consistency, potency, and rich terpene profiles that drive repeat consumer demand and retail velocity across dispensaries nationwide.

"This repeat order from Smoking Scholars is a clear indicator of market trust and long-term partnership potential," said a CBDL company spokesperson. "We've built our reputation around reliability, quality, and innovation - and our Bronx partners see the results firsthand. This momentum is only the beginning."

Bronx Expansion Highlights Growth Wave

As cannabis retail continues to ignite across New York, Smoking Scholars' renewed partnership underscores the borough's thriving local ecosystem and CBDL's strategic ability to align with dispensaries driving cultural and economic progress.

"The Bronx just got greener," said representatives close to the Smoking Scholars expansion. "We're proud to offer premium hybrid, sativa, and indica strains that embody the borough's creativity, resilience, and authenticity."

This collaboration marks another milestone for CBD Life Sciences Inc., reinforcing its operational focus on high-growth territories while broadening national distribution through wholesale partnerships, retail placements, and branded product innovation through The CBD Vault.

Investor Highlights

• Repeat bulk order from major Bronx dispensary strengthens recurring revenue streams.

• Expanded strain lineup - Hawaii Haze, Jet Fuel, Purple Gas - built for high-turnover retail markets.

• Momentum compounding following 1405.46% revenue growth since February 2024.

• Strategic foothold in New York's booming cannabis economy, projected to reach $7.2B by 2030.

• Reinforcing CBDL's long-term mission of innovation, scalability, and sustained shareholder value.

About CBD Life Sciences Inc. (CBDL)

CBD Life Sciences Inc. (OTC Pink: CBDL) is a publicly traded company focused on the development, manufacturing, and distribution of premium CBD, hemp, and cannabis products under its flagship wellness brand, The CBD Vault. From topicals and tinctures to gummies, infused beverages, and now premium strains, The CBD Vault is redefining accessibility, quality, and innovation within the industry.

For more information, visit www.thecbdvault.com or follow on Instagram @thecbdvault.

Follow our social media for the latest updates!
X: https://www.x.com/CBDL_StockOTC
Instagram: https://www.instagram.com/cbd.vault
Website: https://www.thecbdvault.com
IR Contact: [email protected]

Stay Connected & Be the First to Try Our New Functional Mushroom Products!

Mushroom Madness Instagram: https://www.instagram.com/mushroom.madnessaz
Mushroom Madness Website: https://www.mushroommadness.shop

Forward-Looking Statements
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.

Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements.

Contact Information
Lisa Nelson
CEO
[email protected]
4802091720

SOURCE: CBD Life Sciences, Inc.

View the original press release on ACCESS Newswire

A.Taylor--AT